Tianjin Third Central Hospital
32
7
7
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 32 trials
100.0%
+13.5% vs industry average
22%
7 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (32)
Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy
Role: collaborator
Radical Nephrectomy With vs Without Template Lymph Node Dissection in High-Risk Renal Cell Carcinoma (T-LND RCC): A Randomized Clinical Trial
Role: collaborator
Radical Nephroureterectomy With vs Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma (T-LND UTUC): A Randomized Clinical Trial
Role: collaborator
Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction
Role: collaborator
Romiplostim N01 for Chemotherapy-induced Thrombocytopenia
Role: collaborator
Comparison of Short- and Long-term Outcomes Between Robotic and Laparoscopic Hemicolectomy of Right Colon Cancer : A Multicenter Propensity Score Matching Analysis
Role: collaborator
FibroTouch Non-invasive Evaluation of Liver Fibrosis and Cirrhosis
Role: collaborator
Herombopag for Chemotherapy-induced Thrombocytopenia
Role: collaborator
Eltrombopag for Chemotherapy-induced Thrombocytopenia
Role: collaborator
Avatrombopag for Chemotherapy-induced Thrombocytopenia
Role: collaborator
The Safety and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Metastatic Adenocarcinoma
Role: collaborator
Noninvasive Diagnosis Model for High-risk Varices in Cirrhosis
Role: collaborator
A Prospective Study on the Application of Liquid Biopsy in the Surveillance of High-risk Population of HCC.
Role: lead
Nafamostat Mesilate in the Treatment of Severe Infection-associated Coagulopathy
Role: collaborator
Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)
Role: collaborator
Efficacy and Safety of Berberine in Non-alcoholic Steatohepatitis
Role: collaborator
Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF)
Role: collaborator
Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106)
Role: collaborator
Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)
Role: collaborator
Timing of Endoscopy for Acute Variceal Bleeding in Patients With Cirrhosis
Role: collaborator